$KNW
KNOW LABS, INC. Stock $knw

$knw Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000165495422006760 Filed on May 13, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q1
Revenue	$0.00	$8.687K	$0.00
YoY Change			-100.0%
Cost Of Revenue			$0.00
YoY Change			-100.0%
Gross Profit			$0.00
YoY Change			-100.0%
Gross Profit Margin
Selling, General & Admin	$1.589M	$1.448M	$1.343M
YoY Change	59.81%	7.86%	-16.39%
% of Gross Profit
Research & Development	$1.273M	$1.249M	$1.259M
YoY Change	46.51%	-0.79%	181.48%
% of Gross Profit
Depreciation & Amortization	$100.6K	$76.40K	$64.63K
YoY Change	54.83%	18.21%	6.95%
% of Gross Profit
Operating Expenses	$3.025M	$2.851M	$2.601M
YoY Change	62.41%	9.61%	25.66%
Operating Profit	-$3.025M	-$2.843M	-$2.601M
YoY Change	62.41%	9.28%	25.71%
Interest Expense	$239.8K	$3.298M	$2.772M
YoY Change	-95.41%	18.96%	-312.98%
% of Operating Profit
Other Income/Expense, Net	$22.17K	$3.298M	$2.772M
YoY Change	-100.42%	18.96%	6743.49%
Pretax Income	-$3.003M	-$6.141M	-$5.374M
YoY Change	-57.65%	14.28%	61.35%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.003M	-$6.141M	-$5.374M
YoY Change	-57.65%	14.28%	61.35%
Net Earnings / Revenue		-70688.82%
Basic Earnings Per Share
Diluted Earnings Per Share	-$68.63K	-$162.1K	-$201.2K
COMMON SHARES
Basic Shares Outstanding	43.75M shares	36.06M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.352M	$11.19M	$15.70M
YoY Change	-39.78%	-28.73%	1920.8%
Cash & Equivalents	$8.352M	$11.19M	$15.70M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$46.15K	$119.2K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$8.398M	$11.31M	$15.70M
YoY Change	-39.45%	-27.97%	1920.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$953.4K	$1.037M	$183.1K
YoY Change	757.02%	466.73%	-26.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.77K	$13.77K	$13.77K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$1.229M	$1.357M	$211.3K
YoY Change	690.14%	542.16%	-53.2%
TOTAL ASSETS
Total Short-Term Assets	$8.398M	$11.31M	$15.70M
Total Long-Term Assets	$1.229M	$1.357M	$211.3K
Total Assets	$9.627M	$12.66M	$15.91M
YoY Change	-31.36%	-20.4%	1195.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$405.4K	$411.9K	$434.6K
YoY Change	0.12%	-5.23%	-38.1%
Accrued Expenses	$534.0K	$265.9K	$1.440M
YoY Change	-8.84%	-81.54%	57.35%
Deferred Revenue
YoY Change
Short-Term Debt	$2.255M	$2.255M	$5.058M
YoY Change	-54.96%	-55.41%	84.63%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.611M	$5.363M	$8.062M
YoY Change	-41.04%	-33.48%	85.06%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$431.8K	$431.8K
YoY Change	-100.0%	0.0%
Other Long-Term Liabilities	$97.26K	$138.6K	$260.00
YoY Change		53219.23%	-97.99%
Total Long-Term Liabilities	$97.26K	$570.4K	$432.1K
YoY Change	-52.7%	32.03%	3246.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.611M	$5.363M	$8.062M
Total Long-Term Liabilities	$97.26K	$570.4K	$432.1K
Total Liabilities	$4.708M	$5.934M	$8.494M
YoY Change	-41.34%	-30.14%	94.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$95.83M	-$92.82M
YoY Change	29.97%
Common Stock	$43.80K	$43.74K
YoY Change	29.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.919M	$6.729M	$7.414M
YoY Change
Total Liabilities & Shareholders Equity	$9.627M	$12.66M	$15.91M
YoY Change	-31.36%	-20.4%	1195.25%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$3.003M	-$6.141M	-$5.374M
YoY Change	-57.65%	14.28%	61.35%
Depreciation, Depletion And Amortization	$100.6K	$76.40K	$64.63K
YoY Change	54.83%	18.21%	6.95%
Cash From Operating Activities	-$2.669M	$885.8K	-$1.826M
YoY Change	40.7%	-148.5%	111.38%
INVESTING ACTIVITIES
Capital Expenditures	-$16.60K	-$441.5K	-$25.34K
YoY Change	31.96%	1642.19%	104.68%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$16.60K	-$441.5K	-$25.34K
YoY Change	31.96%	1642.19%	104.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-149.3K	9.000K	14.62M
YoY Change	-279.1%	-99.94%	9593.71%
NET CHANGE
Cash From Operating Activities	-2.669M	885.8K	-1.826M
Cash From Investing Activities	-16.60K	-441.5K	-25.34K
Cash From Financing Activities	-149.3K	9.000K	14.62M
Net Change In Cash	-2.835M	453.3K	12.77M
YoY Change	55.23%	-96.45%	-1859.95%
FREE CASH FLOW
Cash From Operating Activities	-$2.669M	$885.8K	-$1.826M
Capital Expenditures	-$16.60K	-$441.5K	-$25.34K
Free Cash Flow	-$2.653M	$1.327M	-$1.801M
YoY Change	40.76%	-173.7%	111.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43752147	shares
CY2022Q1	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	11187073	USD
CY2021Q3	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	12258218	USD
CY2022Q1	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	119210	USD
CY2021Q3	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	0	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	12258218	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	328504	USD
CY2021Q3	us-gaap	Other Assets OtherAssets	13767	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	289002	USD
CY2021Q3	us-gaap	Assets Assets	12889491	USD
CY2021Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	419093	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	893137	USD
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	421599	USD
CY2021Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	9191155	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	112371	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	11037355	USD
CY2021Q3	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	431803	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	178170	USD
CY2021Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	609973	USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43737772	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35166551	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	43739	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	99506534	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-92823851	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	6729227	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12662904	USD
CY2022Q1	us-gaap	Revenues Revenues	8687	USD
CY2021Q1	us-gaap	Revenues Revenues	0	USD
	us-gaap	Revenues Revenues	4360087	USD
	us-gaap	Revenues Revenues	0	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1248707	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1258678	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2134459	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2225539	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1448227	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1342644	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2665174	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3939864	USD
CY2022Q1	us-gaap	Selling Expense SellingExpense	154502	USD
CY2021Q1	us-gaap	Selling Expense SellingExpense	0	USD
	us-gaap	Selling Expense SellingExpense	3272862	USD
	us-gaap	Selling Expense SellingExpense	0	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2851436	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	2601322	USD
	us-gaap	Operating Expenses OperatingExpenses	8072495	USD
	us-gaap	Operating Expenses OperatingExpenses	6165403	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2842749	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2601322	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3712408	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6165403	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	3297989	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	2772296	USD
	us-gaap	Interest Expense InterestExpense	7784949	USD
	us-gaap	Interest Expense InterestExpense	4507546	USD
CY2022Q1	us-gaap	Other Expenses OtherExpenses	3297989	USD
CY2021Q1	us-gaap	Other Expenses OtherExpenses	2772296	USD
	us-gaap	Other Expenses OtherExpenses	7784949	USD
	us-gaap	Other Expenses OtherExpenses	4507546	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6140738	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-5373618	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-11497357	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10672949	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6140738	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-5373618	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11497357	USD
	us-gaap	Net Income Loss NetIncomeLoss	-10672949	USD
CY2022Q1	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.16
CY2021Q1	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.20
	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.31
	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.41
CY2022Q1	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	37872406	shares
CY2021Q1	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	26710585	shares
	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	36655905	shares
	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	25951403	shares
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-1914911	USD
CY2020Q4	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	175442	USD
CY2020Q4	knwn	Issuance Of Warrants For Services Related To Debt Offering Note7 Amount IssuanceOfWarrantsForServicesRelatedToDebtOfferingNote7Amount	561600	USD
CY2020Q4	knwn	Issuance Of Warrant For Services To Related Party IssuanceOfWarrantForServicesToRelatedParty	1811691	USD
CY2020Q4	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	4688	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-5299331	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-4660822	USD
CY2021Q1	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	127407	USD
CY2021Q1	knwn	Issuance Of Warrants For Services Related To Debt Offering Note7 Amount IssuanceOfWarrantsForServicesRelatedToDebtOfferingNote7Amount	210606	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	9769683	USD
CY2021Q1	knwn	Issuance Of Warrants To Debt Holders Note7 IssuanceOfWarrantsToDebtHoldersNote7	4439317	USD
CY2021Q1	knwn	Issuance Of Warrants For Services Related To Debt Offering IssuanceOfWarrantsForServicesRelatedToDebtOffering	1667281	USD
CY2021Q1	knwn	Issuance Of Common Stock For Services Amount IssuanceOfCommonStockForServicesAmount	202820	USD
CY2021Q1	knwn	Issuance Of Warrant For Services To Related Party IssuanceOfWarrantForServicesToRelatedParty	382566	USD
CY2021Q1	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	648516	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-5373618	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	7413756	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1242163	USD
CY2021Q4	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	204170	USD
CY2021Q4	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	766486	USD
CY2021Q4	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	2344	USD
CY2022Q1	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	432481	USD
CY2022Q1	knwn	Issuance Of Warrants For Services Related To Debt Offering Note7 Amount IssuanceOfWarrantsForServicesRelatedToDebtOfferingNote7Amount	15345720	USD
CY2022Q1	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	9000	USD
CY2022Q1	knwn	Issuance Of Common Stock For Services Amount IssuanceOfCommonStockForServicesAmount	153000	USD
CY2022Q1	knwn	Issuance Of Warrant For Services To Related Party IssuanceOfWarrantForServicesToRelatedParty	71220	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6140738	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	6729227	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11497357	USD
	us-gaap	Net Income Loss NetIncomeLoss	-10672949	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	118068	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	129257	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	153000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	202820	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	71220	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	knwn	Right Of Use Net RightOfUseNet	0	USD
	knwn	Stock Based Compensation Warrants StockBasedCompensationWarrants	-2194257	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	636651	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	302849	USD
	knwn	Right Of Use Net RightOfUseNet	-11203	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7272911	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4198105	USD
	knwn	Proceeds From Simple Agreements For Future Equity ProceedsFromSimpleAgreementsForFutureEquity	0	USD
	us-gaap	Gain Loss On Sale Of Accounts Receivable GainLossOnSaleOfAccountsReceivable	-634	USD
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	119210	USD
	knwn	Proceeds From Note Payableppp ProceedsFromNotePayableppp	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-11413	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2353901	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	386261	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1022019	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3247353	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	826956	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	34967	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-826956	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-34967	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	14209000	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	727117	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
	knwn	Proceeds From Simple Agreements For Future Equity ProceedsFromSimpleAgreementsForFutureEquity	340000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
	knwn	Proceeds From Note Payableppp ProceedsFromNotePayableppp	205633	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11344	USD
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	766486	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	653204	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	777830	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14680720	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1071145	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	11398400	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12258218	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4298179	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11187073	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15696579	USD
	knwn	Adjustments To Additional Paid In Capital Warrant Issued For Services AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServices	0	USD
	knwn	Cashless Warrant Exercise CashlessWarrantExercise	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	9769683	USD
	knwn	Adjustments To Additional Paid In Capital Warrant Issued For Services AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServices	1667281	USD
	knwn	Cashless Warrant Exercise CashlessWarrantExercise	493601	USD
	knwn	Conversion Of Debt Offering ConversionOfDebtOffering	14209000	USD
	knwn	Conversion Of Debt Offering ConversionOfDebtOffering	713775	USD
	knwn	Conversion Of Accrued Interest ConversionOfAccruedInterest	1136720	USD
	knwn	Conversion Of Accrued Interest ConversionOfAccruedInterest	58430	USD
CY2021Q3	knwn	Authorized Shares Of Capital Common Stock AuthorizedSharesOfCapitalCommonStock	205000000	shares
CY2022Q1	knwn	Authorized Shares Of Capital Common Stock AuthorizedSharesOfCapitalCommonStock	200000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	knwn	Authorized Common Stock Increased AuthorizedCommonStockIncreased	200000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Proceeds From Sale Of Other Assets1 ProceedsFromSaleOfOtherAssets1	4360000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11187073	USD
CY2022Q1	knwn	Working Capital WorkingCapital	8355273	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-92823851	USD
CY2022Q1	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	250000	USD
	knwn	Revenue Recognition Policy Textblock RevenueRecognitionPolicyTextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Revenue Recognition </strong>- The Company determines revenue recognition from contracts with customers through the following steps:</p><table cellpadding="0" style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the contract, or contracts, with the customer;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the performance obligations in the contract;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">determination of the transaction price;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">allocation of the transaction price to the performance obligations in the contract; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">recognition of the revenue when, or as, the Company satisfies a performance obligation.</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. During the six months ended March 31, 2022, the Company’s artificial intelligence (AI) Deep Learning Platform began generating revenue from digital asset sales of NFT’s. The Company engineering team, using its research date, AI and proprietary algorithms, produced NFT’s in the form of digital art. The NFT’s produced had no recorded cost basis. </p>
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2134459	USD
	us-gaap	Advertising Expense AdvertisingExpense	387434	USD
	us-gaap	Advertising Expense AdvertisingExpense	162933	USD
CY2022Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	8036515	USD
CY2021Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	12217714	USD
	us-gaap	Derivatives Methods Of Accounting Hedge Effectiveness DerivativesMethodsOfAccountingHedgeEffectiveness	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Derivative Financial Instruments –</strong>Pursuant to ASC 815 “Derivatives and Hedging”, the Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company then determines if embedded derivative must be bifurcated and separately accounted for. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined that the conversion features for purposes of bifurcation within convertible notes payable were immaterial and there was no derivative liability to be recorded as of March 31, 2022 and September 30, 2021.</p>
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43737772	shares
CY2022Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	2255066	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28257467	shares
CY2021Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	19133500	shares
CY2022Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26855	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	474829	USD
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Use of Estimates</strong> – The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
	knwn	Artificial Intelligence Ai Deep Learning Platform ArtificialIntelligenceAiDeepLearningPlatform	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>4. Artificial Intelligence (AI) Deep Learning Platform</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>AI Revenue</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six months ended March 31, 2022,<strong> </strong>the<strong> </strong>Company’s artificial intelligence (AI) Deep Learning Platform began generating revenue from digital asset sales of NFT’s and had sales of $4,360,087. The Company’s sales of NFT’s are generated using the NFT digital exchange, OpenSea. Customers purchasing the NFT’s must make payments in the crypto currency, Ethereum. The Ethereum is received into a digital wallet and then moved to an account at Coinbase where the Ethereum is converted to U.S. dollars. During the three months ended December 31, 2021, the Company was not able to establish a digital wallet and corporate account at Coinbase in order to receive the Ethereum. The Company used the digital wallet and Coinbase account of the Company’s CEO. The Company and the CEO executed an assignment of his account to the Company while the Company establishes its own Coinbase account. All proceeds received from the sale of NFT were deposited in the CEO’s personal digital accounts. As of December 31, 2021 the Company had recorded an accounts receivable-related party of $3,124,581 for the cash it expected to receive from the CEO’s personal digital account.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2022, the Company was able to establish a digital wallet and corporate account at Circle in order to receive the Ethereum and then convert it to cash. The Company received $2,908,551 of Ethereum and recorded a reduction in value of $96,820 related to the decline in value of the Ethereum. The accounts receivable-related party was $119,210 as of March 31, 2022. As of March 31, 2022, accrued expenses - related parties include approximately $326,378 of expenses, primarily sales and use tax and $1,564,852 in compensation that the Company expects to pay for the NFT sales. During 2021, approximately $1.3 million of the selling and transactional costs for the digital assets was paid through the CEO’s personal digital asset account including approximately $1.075 million which was paid to a consultant via the transfer of Ethereum.</p>
CY2022Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1481754	USD
CY2021Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	654798	USD
CY2021Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3612	USD
CY2022Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3612	USD
CY2021Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26855	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	356761	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1037392	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	328504	USD
	us-gaap	Depreciation Depreciation	118068	USD
	us-gaap	Depreciation Depreciation	42591	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	305462	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	295798	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	290000	USD
	us-gaap	Lease Cost LeaseCost	100103	USD
	us-gaap	Lease Cost LeaseCost	76423	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	50051	USD
	knwn	Finance Leases Weighted Average Remaining Lease Term FinanceLeasesWeightedAverageRemainingLeaseTerm	P23Y
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	170489	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	117941	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	27411	USD
CY2022Q1	knwn	Total Remaining Payments TotalRemainingPayments	315840	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	20042	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	295798	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y9M18D
CY2022Q1	knwn	Convertible Notes Conversions ConvertibleNotesConversions	-14209000	USD
CY2021Q3	knwn	Convertible Notes Conversions ConvertibleNotesConversions	-5639500	USD
CY2021Q3	knwn	Debt Discount Beneficial Conversion Feature DebtDiscountBeneficialConversionFeature	-4308337	USD
CY2021Q3	knwn	Debt Discount Warrants DebtDiscountWarrants	-1957590	USD
CY2021Q3	knwn	Debt Discount Warrants Issued For Services DebtDiscountWarrantsIssuedForServices	-1056984	USD
CY2022Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2255066	USD
CY2021Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	9191155	USD
CY2022Q1	knwn	Options To Purchase Common Stock Share OptionsToPurchaseCommonStockShare	17878245	shares
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Unearned ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUnearned	11550745	shares
CY2022Q1	knwn	Warrant Issued To Common Stock WarrantIssuedToCommonStock	21714023	shares
CY2022Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2255066	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22564255	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.998
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	60000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	801486	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.956
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	108756	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	21714013	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.001
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	21714013	shares
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	21714013	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	19956371	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	636651	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	302849	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5313062	USD
CY2019Q3	knwn	Share Based Compensation Arrangement By Share Based Payment Awards Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsOutstandingWeightedAverageExercisePrice	2.025
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9180369	USD
CY2020	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsGrantsInPeriodWeightedAverageExercisePrice	1.142
CY2020	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted	3522400	USD
CY2020	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsExercisesInPeriodWeightedAverageExercisePrice	0.250
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	18298	USD
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.593
CY2020	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitures	-7103921	USD
CY2020Q3	knwn	Share Based Compensation Arrangement By Share Based Payment Awards Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsOutstandingWeightedAverageExercisePrice	1.161
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5580550	USD
CY2021	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsGrantsInPeriodWeightedAverageExercisePrice	1.766
CY2021	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted	18807990	USD
CY2021	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsExercisesInPeriodWeightedAverageExercisePrice	1.359
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	28031	USD
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.300
CY2021	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitures	-396000	USD
CY2021Q3	knwn	Share Based Compensation Arrangement By Share Based Payment Awards Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsOutstandingWeightedAverageExercisePrice	1.565
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23964509	USD
	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsGrantsInPeriodWeightedAverageExercisePrice	2.087
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted	7062900	USD
	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsExercisesInPeriodWeightedAverageExercisePrice	1.650
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	11344	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.842
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitures	-1501350	USD
CY2022Q1	knwn	Share Based Compensation Arrangement By Share Based Payment Awards Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsOutstandingWeightedAverageExercisePrice	1.651
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	29514715	USD
CY2021Q4	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	3124581	USD
	knwn	Special Bonus Compensation SpecialBonusCompensation	1560000	USD
	knwn	Sales And Use Tax SalesAndUseTax	326000	USD
	knwn	Selling And Transactional Costs SellingAndTransactionalCosts	1300000	USD
	knwn	Amount Paid To Consultant AmountPaidToConsultant	1075000.000	USD
CY2022Q1	us-gaap	Cash Cash	2908551	USD
CY2022Q1	knwn	Reduction In Value Of Related To The Ethereum ReductionInValueOfRelatedToTheEthereum	96820	USD
	knwn	Accounts Receivable Related Party AccountsReceivableRelatedParty	119210	USD
CY2022Q1	knwn	Accrued Expenses AccruedExpenses	326378	USD
CY2022Q1	knwn	Selling And Transactional Cost SellingAndTransactionalCost	156485200000	USD
CY2017Q2	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	3334	USD
CY2017Q2	knwn	Lease Description LeaseDescription	lease expires on May 31, 2022
CY2021Q4	knwn	Lease Description LeaseDescription	the Company extended the lease from June 1, 2022 to May 31, 2023 at $2,986 per month.
CY2019Q1	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	8697	USD
CY2019Q1	knwn	Lease Description LeaseDescription	The lease expires on June 30, 2024
CY2021Q4	knwn	Lease Description LeaseDescription	the Company entered into First Amendment of Lease and added 1,030 square feet for year for $1,000 for $5,000 per month.
CY2022Q1	knwn	Segment Revenues SegmentRevenues	9000	USD
CY2022Q1	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-2843000	USD
CY2022Q1	knwn	Segment Assets SegmentAssets	12663000	USD
CY2021Q1	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-2602000	USD
CY2021Q1	knwn	Segment Assets SegmentAssets	15908000	USD
	knwn	Segment Revenues SegmentRevenues	4361000	USD
	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-3712000	USD
	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-6165000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	8240647	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	7027922	USD
	knwn	Schedule Of Extension Of Warrant Agreement ScheduleOfExtensionOfWarrantAgreement	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Warrant No./Class</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Issue Date</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">No. Warrant Shares</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Exercise Price</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Original Expiration Date</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Amended Expiration Date</p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Clayton A. Struve Warrant </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">08-14-2017</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,440,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.25</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">08-13-2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">08-13-2024</p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Clayton A. Struve Warrant </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">12-12-2017</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,200,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.25</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">12-11-2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">12-11-2024</p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Clayton A. Struve Warrant</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">08-04-2016</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,785,715</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.25</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">08-04-2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">08-04-2024</p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Clayton A. Struve Warrant</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">02-28-2018</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,344,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.25</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">02-28-2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">02-28-2024</p></td><td style="width:1%;"> </td></tr></tbody></table>

Files In Submission

Name	View Source	Status
0001654954-22-006760-index-headers.html	Edgar Link	pending
0001654954-22-006760-index.html	Edgar Link	pending
0001654954-22-006760.txt	Edgar Link	pending
0001654954-22-006760-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
knwn-20220331.xsd	Edgar Link	pending
knwn-20220331_cal.xml	Edgar Link	unprocessable
knwn-20220331_def.xml	Edgar Link	unprocessable
knwn-20220331_lab.xml	Edgar Link	unprocessable
knwn-20220331_pre.xml	Edgar Link	unprocessable
knwn_10q.htm	Edgar Link	pending
knwn_10qimg2.jpg	Edgar Link	pending
knwn_10q_htm.xml	Edgar Link	completed
knwn_ex311.htm	Edgar Link	pending
knwn_ex312.htm	Edgar Link	pending
knwn_ex321.htm	Edgar Link	pending
knwn_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KNW
KNOW LABS, INC. Stock $knw

2022 Q2 Form 10-Q Financial Statement

#000165495422006760 Filed on May 13, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW KNOW LABS, INC. Stock $knw

2022 Q2 Form 10-Q Financial Statement

#000165495422006760 Filed on May 13, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW
KNOW LABS, INC. Stock $knw